Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

Case Report: Drug-Induced Immune Haemolytic Anaemia Caused by Cefoperazone-Tazobactam/ Sulbactam Combination Therapy

There has previously been a report of a patient developing haemolytic anaemia following exposure to cefoperazone. Another case has been reported involving the detection of cefoperazone-dependent antibodies in the absence of immune haemolytic anaemia. To date, no serological evidence has been reporte...

Full description

Bibliographic Details
Main Authors: Yuanjun Wu, Yong Wu, Yanli Ji, Jiajie Liang, Ziyi He, Yanhui Liu, Li Tang, Ganping Guo
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Medicine
Subjects:
cefoperazone
tazobactam
sulbactam
cefoperazone-dependent antibodies
nonimmunologic protein adsorption (NIPA)
druginduced immune hemolytic anaemia (DIIHA)
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.697192/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.697192/full

Similar Items